This needs to be added to the Finasteride Wikipedia page immediately.
That’s huge! What’s even better (or worse?) is that the study was done by Eli Lilly – one of Merck’s competitors.
Good to know the industry is not against attacking their colleagues.
Pleased to see more damning evidence being published. However, their conclusion seems to imply that suicidle ideation is nothing more than distress brought on by developing sexual dysfunction, and not a symptom in its own right, or part of a set of cognitive symptoms.
I didn’t notice that, I looked at the authors and figured they were independent researchers… lol big pharma attacking big pharma… can’t beat that.
How can we contact Eli Lilly’s then and ask for their help?
Unless they get funding I doubt they will be interested. Their a for-profit organization like their competitors. We are a relatively small segment not really worth them investigating wholly out of profit concerns… unless they are interested in creating potentially negative press for their competitors which is always a possibility.
Here’s a thought: what if…
Lilly is a therapy drug in mind for PFS?
Now THAT would be a killer PR move – one major pharma company cleans up the damage of another.
Hit em up and ask!!